RxDoctor Payments Data

Cassidy Rhodes, DO

Family Medicine · van Buren, ARNPI 1053992909

Payments from drug & device makers

$484in general payments, 2019–2025

Across 24 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$96
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$93
  • AstraZeneca$74
  • Exact Sciences$50
  • Novo Nordisk$37
  • GSK$22
  • plus $111 from 7 others

What the payments were for

  • Food & beverage$484100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$484 in reported general payments places this provider in the 45th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$19,645
Medicare patients
87
Services billed
365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$20,761
OzempicSemaglutide17$20,158
TrulicityDulaglutide13$16,468
Tresiba Flextouch U-200Insulin Degludec15$12,508
RestasisCyclosporine12$7,781
Breo ElliptaFluticasone/Vilanterol13$7,613
Gabapentin101$1,562
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen60$1,443
Nitroglycerin20$1,153
Albuterol Sulfate HfaAlbuterol Sulfate44$1,043
Quetiapine Fumarate28$644
Omeprazole54$554
Cyclobenzaprine Hcl33$429
Ondansetron OdtOndansetron25$367
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$335

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$22$28,37437 claims
Novo NordiskOzempic$37$20,15817 claims
Lilly USA, LLCTrulicity$14$16,46813 claims
AbbVieRestasis$14$7,78112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in van Buren

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →